* Inogen Inc INGN.OQ reported a quarterly adjusted loss
of 62
cents per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -88
cents. The mean expectation of four analysts for the quarter
was for a loss of 76 cents per share. Wall Street expected
results to range from -85 cents to -65 cents per share.
* Revenue rose 8.1% to $78.03 million from a year ago;
analysts
expected $73.66 million.
* Inogen Inc's reported EPS for the quarter was a loss of 62
cents.
* The company reported a quarterly loss of $14.58 million.
* Inogen Inc shares had fallen by 10.9% this quarter and
gained 31.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 21.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Inogen Inc is
$6.50
This summary was machine generated from LSEG data May 7 at 11:14
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.76 -0.62 Beat
Dec. 31 2023 -0.62 -1.14 Missed
Sep. 30 2023 -0.49 -0.55 Missed
Jun. 30 2023 -0.59 -0.42 Beat